BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrade MC, Ferreira SB, Gonçalves LC, De-Paula AM, de Faria ES, Teixeira-Carvalho A, Martins-Filho OA. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma. Hum Immunol 2013;74:1563-74. [PMID: 23994583 DOI: 10.1016/j.humimm.2013.08.272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Niu M, Combs SE, Linge A, Krause M, Baumann M, Lohaus F, Ebert N, Tinhofer I, Budach V, von der Grün J, Rödel F, Grosu AL, Multhoff G. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiat Oncol 2021;16:141. [PMID: 34332614 DOI: 10.1186/s13014-021-01868-5] [Reference Citation Analysis]
2 Wolf GT, Moyer JS, Kaplan MJ, Newman JG, Egan JE, Berinstein NL, Whiteside TL. IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers. Onco Targets Ther 2018;11:3731-46. [PMID: 29988729 DOI: 10.2147/OTT.S165411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
3 Schneider K, Marbaix E, Bouzin C, Hamoir M, Mahy P, Bol V, Grégoire V. Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study. Acta Oncol 2018;57:1165-72. [PMID: 29493423 DOI: 10.1080/0284186X.2018.1445287] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
4 De Keukeleire SJ, Vermassen T, Hilgert E, Creytens D, Ferdinande L, Rottey S. Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives. Cancers (Basel) 2021;13:1714. [PMID: 33916646 DOI: 10.3390/cancers13071714] [Reference Citation Analysis]
5 Leduc C, Adam J, Louvet E, Sourisseau T, Dorvault N, Bernard M, Maingot E, Faivre L, Cassin-Kuo MS, Boissier E, Dessoliers MC, Robin A, Casiraghi O, Even C, Temam S, Olaussen KA, Soria JC, Postel-Vinay S. TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma. ESMO Open 2018;3:e000257. [PMID: 29344407 DOI: 10.1136/esmoopen-2017-000257] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]